Great Valley Advisor Group, Inc. Abbott Laboratories Transaction History

Great Valley Advisor Group, Inc.

$3.84 Billion
Q3 2024

A detailed history of Great Valley Advisor Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 24,902 shares of ABT stock, worth $2.84 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

24,902

Previous 24,802 0.4%

Holding current value

$2.84 Million

Previous $2.58 Million 10.17%

% of portfolio

0.07%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $10,007 - $11,813	100 Added 0.4%	24,902 $2.84 Million
Q2 2024 Jul 16, 2024	BUY	$100.73 - $112.44 $133,769 - $149,320	1,328 Added 5.66%	24,802 $2.58 Million
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $12,704 - $14,031	-116 Reduced 0.49%	23,474 $2.67 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $3,787 - $4,636	-42 Reduced 0.18%	23,590 $2.6 Million
Q3 2023 Nov 06, 2023	SELL	$95.53 - $114.62 $39,262 - $47,108	-411 Reduced 1.71%	23,632 $2.29 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $323,705 - $360,675	3,212 Added 15.42%	24,043 $2.62 Million
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $609,733 - $717,692	-6,295 Reduced 23.21%	20,831 $2.11 Million
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $141,639 - $166,164	-1,490 Reduced 5.21%	27,126 $2.98 Million
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $173,684 - $201,093	-1,795 Reduced 5.9%	28,616 $2.77 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $346,527 - $418,841	3,395 Added 12.57%	30,411 $3.3 Million
Q1 2022 Apr 20, 2022	BUY	$114.02 - $139.04 $51,879 - $63,263	455 Added 1.71%	27,016 $3.39 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $341,968 - $418,721	2,960 Added 12.54%	26,561 $3.56 Million
Q3 2021 Oct 14, 2021	BUY	$116.66 - $129.06 $147,108 - $162,744	1,261 Added 5.64%	23,601 $2.79 Million
Q2 2021 Jul 27, 2021	BUY	$105.79 - $124.53 $443,048 - $521,531	4,188 Added 23.07%	22,340 $2.62 Million
Q1 2021 Apr 20, 2021	SELL	$108.84 - $128.23 $33,849 - $39,879	-311 Reduced 1.68%	18,152 $2.18 Million
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $5,775 - $6,293	-55 Reduced 0.3%	18,463 $2.02 Million
Q3 2020 Oct 21, 2020	SELL	$91.64 - $111.29 $6,598 - $8,012	-72 Reduced 0.39%	18,518 $2.02 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $561,181 - $718,242	7,329 Added 65.08%	18,590 $1.7 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $55,344 - $80,928	881 Added 8.49%	11,261 $889,000
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $25,672 - $28,579	-327 Reduced 3.05%	10,380 $902,000
Q3 2019 Oct 25, 2019	BUY	$81.84 - $88.74 $32,654 - $35,407	399 Added 3.87%	10,707 $895,000
Q2 2019 Jul 30, 2019	BUY	$72.88 - $85.0 $947 - $1,105	13 Added 0.13%	10,308 $865,000
Q1 2019 Apr 26, 2019	BUY	$66.22 - $80.06 $129,526 - $156,597	1,956 Added 23.46%	10,295 $822,000
Q4 2018 Apr 11, 2019	BUY	$65.56 - $74.27 $546,704 - $619,337	8,339 New	8,339 $602,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Account

Great Valley Advisor Group, Inc. Abbott Laboratories Transaction History